ABCA1 and biogenesis of HDL

Journal of Atherosclerosis and Thrombosis

Volumn 13, Issue 1, 2006, Pages 1-15

  Yokoyama, Shinji ^a  

^a NAGOYA CITY UNIVERSITY GRADUATE SCHOOL OF MEDICAL SCIENCES   (Japan)

Author keywords

ABCA1; Apolipoprotein; Caveolin; Cholesterol efflux; HDL; Membrane

Indexed keywords

ABC TRANSPORTER; ABC TRANSPORTER A1; DNA; HIGH DENSITY LIPOPROTEIN CHOLESTEROL;

ANIMAL; ATHEROSCLEROSIS; BIOGENESIS; GENE EXPRESSION; GENETICS; HUMAN; METABOLISM; PHYSIOLOGY; REVIEW; TRANSPORT AT THE CELLULAR LEVEL;

ANIMALS; ATHEROSCLEROSIS; ATP-BINDING CASSETTE TRANSPORTERS; BIOGENESIS; BIOLOGICAL TRANSPORT; CHOLESTEROL, HDL; DNA; GENE EXPRESSION; HUMANS;

EID: 33745791394     PISSN: 13403478     EISSN: 18803873     Source Type: Journal    
DOI: 10.5551/jat.13.1     Document Type: Review

References (136)

1. Bjorkhem I, Andersson O, Diczfalusy U, Sevastik B, Xiu R-j, Duan C, and Lund E: Atherosclerosis and sterol 27-hydroxylase: Evidence for a role of this enzyme in elimination of cholesterol from human macrophages. Proc Natl Acad Sci USA, 91: 8592-8596, 1994
2. Babiker A, Andersson O, Lund E, Xiu R-J, Deeb S, Reshef A, Leitersdorf E, Diczfalusy U, and Bjoerkhem I: Elimination of cholesterol in macrophages and endothelial cells by the sterol 27-hydroxylase mechanism: Comparison with high density lipoprotein-mediated reverse cholesterol transport. J Biol Chem, 272: 26253-26261, 1997
3. Brown MS and Goldstein JL: A receptor-mediated pathway for cholesterol homeostasis. Science, 232: 34-47, 1986
4. Brown MS and Goldstein JL: A proteolytic pathway that controls the cholesterol content of membranes, cells, and blood. Proc Natl Acad Sci USA, 96: 11041-11048, 1999
5. Horton JD, Goldstein JL, and Brown MS: SREBPs: activators of the complete program of cholesterol and fatty acid synthesis in the liver. J Clin Invest, 109: 1125-1131, 2002
6. Acton S, Rigotti A, Landschulz KT, Xu S, Hobbs HH, and Krieger M: Identification of scavenger receptor SR-BI as a high density lipoprotein receptor. Science, 271: 518-520, 1996
7. Ng DS, Francone OL, Forte TM, Zhang J, Haghpassand M, and Rubin EM: Disruption of the murine lecithin: cholesterol acyltransferase gene causes impairment of adrenal lipid delivery and up-regulation of scavenger receptor class B type I. J Biol Chem, 272: 15777-15781, 1997
8. Fielding CJ and Fielding PE: Molecular physiology of reverse cholesterol transport. J Lipid Res, 36: 211-228, 1995
9. Gordon DJ and Rifkind BM: High density lipoprotein - The clinical implications of recent studies. New Eng J Med, 321: 1311-1316, 1989
10. Ho YK, Brown MS, and Goldstein JL: Hydrolysis and excretion of cytoplasmic cholesterol esters by macrophages: Stimulation by high density lipoprotein and other agents. J Lipid Res, 21: 391-398, 1980
11. Oram JF and Yokoyama S: Apolipoprotein-mediated removal of cellular cholesterol and phospholipids. J Lipid Res, 37: 2473-2491, 1996
12. Yokoyama S: Apolipoprotein-mediated cellular cholesterol efflux. Biochim Biophys Acta, 1392: 1-15, 1998
13. Yokoyama S: Release of cellular cholesterol: Molecular mechanism for cholesterol homeostasis in cells and in the body. Biochim Biophys Acta, 1529: 231-244, 2000
14. Ji Y, Jian B, Wang N, Sun Y, Moya MdIL, Phillips MC, Rothblat GH, Swaney JB, and Tall AR: Scavenger receptor BI promotes high density lipoprotein-mediated cellular cholesterol efflux. J Biol Chem, 272: 20982-20985, 1997
15. de La Llera-Moya M, Connelly MA, Drazul D, Klein SM, Favari E, Yancey PG, Williams DL, and Rothblat GH: Scavenger receptor class B type I affects cholesterol homeostasis by magnifying cholesterol flux between cells and HDL. J Lipid Res, 42: 1969-1978, 2001
16. Wang N, Lan D, Chen W, Matsuura F, and Tall AR: ATP-binding cassette transporters G1 and G4 mediate cellular cholesterol efflux to high-density lipoproteins. Proc Natl Acad Sci USA, 101: 9774-97749, 2004
17. Hara H and Yokoyama S: Interaction of free apolipoprotein with macrophages: Fon-nation of high density lipoprotien-like lipoproteins and reduction of cellular cholesterol. J Biol Chem, 266: 3080-3086, 1991
18. Forte TM, Goth-Goldstein R, Nordhausen RW, and McCall MR: Apolipoprotein A-I-cell membrane interaction: extracellular assembly of heterogeneous nascent HDL particles. J Lipid Res, 34: 317-324, 1993
19. Forte TM, Bielicki JK, Knoff L, and McCall MR: Structural relationships between nascent apoA-I-containing particles that are extracellularly assembled in cell culture. J Lipid Res, 37:1076-1085, 1996
20. Czarnecka H and Yokoyama S: Lecithin: cholesterol acyltransferase reaction on cellular lipid released by free apolipoprotein-mediated efflux. Biochemistry, 34: 4385-4392, 1995
21. Forte TM, Bielicki JK, Goth-Goldstein R, Selmek J, and McCall MR: Recruitment of cell phospholipids and cholesterol by apolipoproteins A-II and A-I formation of nascent apolipoprotein-specific HDL that differ in size, phospholipid composition, and reactivity with LCAT. J Lipid Res, 36:148-157, 1995
22. Hara H, Hara H, Komaba A, and Yokoyama S: α-Helical requirements for free apolipoproteins to generate HDL and to induce cellular lipid efflux. Lipids, 27: 302-304, 1992
23. Yancey PG, Bielicki JK, Johnson WJ, Lund-Katz S, Palgunachari MN, Anantharamaiah GM, Segrest JP, Phillips MC, and Rothblat GH: Efflux of cellular cholesterol and phospholipid to lipid-free apolipoproteins and class A amphipathic peptides. Biochemistry, 34: 7955-7965, 1995
24. Mendez AJ, Anantharamaiah GM, Segrest JP, and Oram JF: Synthetic amphipathic helical peptides that mimic apolipoprotein A-I in clearing cellular cholesterol. J Clin Invest, 94: 1698-1705, 1994
25. Remaley AT, Thomas F, Stonik A Demosky SJ, Bark SE, Neufeld EB, Bocharov AV, Vishnyakova TG, Patterson AP, Eggerman TL, Santamarina-Fojo S, and Brewer HB: Synthetic amphipathic helical peptides promote lipid efflux from cells by an ABCA1-dependent and an ABCA1-independent pathway. J Lipid Res, 44: 828-836, 2003
26. Li Q, Komaba A, and Yokoyama S: Cholesterol is poorly available for free apolipoprotein-mediated cellular lipid efflux from smooth muscle cells. Biochemistry, 32: 4597-4603, 1993
27. Czarnecka H and Yokoyama S: Regulation of cellular cholesterol efflux by lecithin: cholesterol acyltransferase reaction through nonspecific lipid exchange. J Biol Chem, 271: 2023-2028, 1996
28. Li Q, Czamecka H, and Yokoyama S: Involvement of cellular surface factors in lipid-free apolipoprotein-mediated cellular cholesterol efflux. Biochim Biophys Acta, 1259: 227-234, 1995
29. Karlin JB, Johnson WJ, Benedict CR, Chacko GK, Phillips MC, and Rothblat GH: Cholesterol flux between cells and high density lipoprotein: Lack of relationship to specific binding of the lipoprotein to the cell surface. J Biol Chem, 262: 12557-12564, 1987
30. Sakr SW, Williams DL, Stoudt GW, Phillips MC, and Rothblat GH: Induction of cellular cholesterol efflux to lipid-free apolipoprotein A-I by cAMP. Biochim Biophys Acta, 1438: 85-98, 1999
31. Smith JD, Miyata M, Ginsberg M, Grigaux C, Shmookler E, and Plump AS: Cyclic AMP induces apolipoprotein E binding activity and promotes cholesterol efflux from macrophage cell line to apolipoprotein acceptors. J Biol Chem, 271: 30647-30655, 1996
32. Takahashi Y and Smith JD: Cholesterol efflux to apolipoprotein A-I involves endocytosis and resecretion in a calcium-dependent pathway. Proc Natl Acad Sci USA, 96: 11358-11363, 1999
33. Mendez AJ and Uint L: Apolipoprotein-mediated cellular cholesterol and phospholipid efflux depend on a functional Golgi apparatus. J Lipid Res, 37: 2510-2524, 1996
34. Assmann G, von Eckardstein A, and Brewer HB Jr: Familial Analphalipoproteinemia: Tangier Disease. In The Metabolic and Molecular Basis of Inherited Disease 8th Edition. C.R. Scriver, A.C. Beaudet, D. Valle, and W.S. Sly, editors. New York: McGraw-Hill, 2937-2960, 2001
35. Francis GA, Knopp RH, and Oram JF: Defective removal of cellular cholesterol and phospholipids by apolipoprotein A-I in Tangier disease. J Clin Invest, 96: 78-87, 1995
36. Remaley AT, Schumacher UK, Stonik JA, Farsi BD, Nazih HB, and Brewer HBJ: Decreased reverse cholesterol transport from Tangier disease fibroblasts: Acceptor specificity and effect of brefeldin on lipid efflux. Arterioscler. Thromb Vasc Biol, 17: 1813-1821, 1997
37. Brooks-Wilson A, Marcil M, Clee SM, Zhang L-H, Roomp K, Dam Mv, Brewer C, Collins JA, Molhuizen HOF, Loubser D, Ouelette BFF, Fchter K, Asbourne-Excoffon KJD, Sensen C, Scherer S, Mott S, Denis M, Martindale D, Frohlich J, Morgan K, Koop B, Pimstone S, Kastelein JJP, Genest JJ, and Hayden MR: Mutations in ABC1 in tangier disease and familial high-density lipoprotein deficiency. Nature Genetics, 22: 336-345, 1999
38. Bodzioch M, Orso E, Klucken J, Langmann T, Boftcher A, Diederrich W, Drobnic W, Barlage S, Buchler C. Porsch-Ozucurumez M, Kaminski WE, Hahmann HW, Oette K, Rothe G, Aslanidis C, Lackner KJ, and Schmitz G: The gene encoding ATP-binding cassette transporter 1 is mutated in Tangier disease. Nature Genetics, 22: 347-351, 1999
39. Rust S, Rosier M, Funke H, Real J, Amoura Z, Piette J-C, Deleuze J-F, Brewer HB, Duverger N, Denefle P, and Assmann G: Tangier disease is caused by mutations in the gene encoding ATP binding-cassette transporter 1. Nature Genetics, 22: 352-355, 1999
40. Lawn RM, Wade DP, Garvin MR, Wang X, Schwartz K, Porter JG, Seilhamer JJ, Vaughan AM, and Orarn JF: The Tangier disease gene product ABC1 controls the cellular apolipoprotein-mediated lipid removal pathway. J Clin Invest, 104: R25-R31, 1999
41. Remaley AT, Rust S, Rosier M, Knapper C, Naudin L, Broccardo C, Peterson KM, Koch C, Arnould I, Prades C, Duverger N, Funke H, Assman G, Dinger M, Dean M, Chimini G, Santamarina-Fojo S, Fredrickson DS, Denefle P, and Brewer HB Jr Human ATP-binding cassette transporter 1 (ABC1): Genomic organization and identification of the genetic defect in the original Tangier disease kindred. Proc Natl Acad Sci, 96: 12685-12690, 1999
42. Marcil M, Brooks-Wilson A, Clee SM, Roomp K, Zhang LK, Yu L, Collins JA, van Dam M, Molhuizen HO, Loubster O, Ouellette BF, Sensen CW, Fichter K, Mott S, Denis M, Boucher B, Pimstone S, Genest J Jr, Kastelein JJ, and Hayden MR: Mutations in the ABC1 gene in familial HDL deficiency with defective cholesterol efflux. Lancet, 354: 1341-1346, 1999
43. Orso E, Broccardo C, Kaminski WE, BOttcher A, Liebisch G, Drobnik W, Gotz A, Chambenoit O, Diederich W, Langmann T, Spruss T, Luciani M-F, Rothe G, Lackner KJ, Chimini G, and Schmitz G: Transport of lipids from Golgi to plasma membrane is defective in Tangier disease patients and abc1-deficient mice. Nature Genetics, 24: 192-196, 2000
44. McNeish J, Aiello RJ, Guyot D, Turi T, Gabel C, Aldinger C, Hoppe KL, Roach ML, Royer LJ, de Wet J, Broccardo C, Chimini G, and Francone OL: High ensity lipoprotein deficiency and foam cell accumulation in mice with targeted disruption of ATP binding cassette transporter-1. Proc Natl Acad Sci USA, 97: 4245-4250, 2000
45. Abe-Dohmae S, Suzuki S, Wada Y, Aburatani H, Vance DE, and Yokoyama S: Characterization of apolipoprotein-mediated HDL generation induced by cAMP in a murine macrophage cell line. Biochemistry, 39: 11092-11099, 2000
46. Oram JF, Lawn RM, Garvin MR, and Wade DP: ABCA1 is the cAMP-inducible apolipoprotein receptor that mediates cholesterol secretion from macrophages. J Biol Chem, 275: 34508-34511, 2000
47. Wang N, Silver DL, Costet P, and Tall AR: Specific übinding of apoA-I, enhanced cholesterol efflux and altered plasma membrane morphology in cells expressing ABC1. J Biol Chem, 275: 33053-33058, 2000
48. Fitzgerald ML, Morris AL, Chroni A, Mendez AJ, Zannis VI, and Freeman MW: ABCA1 and amphipathic apolipoproteins form high-affinity molecular complexes required for cholesterol efflux. J Lipid Res, 45: 287-294, 2004
49. Singaraja RR, Brunham LR, Visscher H, Kastelein JJ, and Hayden MR: Efflux and atherosclerosis: the clinical and biochemical impact of variations in the ABCA1 gene. Arterioscler Thromb Vasc Biol, 23, 2003
50. Abe-Dohmae S, Ikeda Y, Matsuo M, Hayashi M, Okuhira K, Ueda K, and Yokoyama S: Human ABCA7 supports apolipoprotein-mediated release of cellular cholesterol and phospholipid to generate high density lipoprotein. J Biol Chem, 279: 604-611, 2004
51. Wang N, Lan D, Gerbod-Giannone M, Linsel-Nitschke P, Jehle AW, Chen W, Martinez LO, and Tall AR: ATP-binding cassette transporter A7 (ABCA7) binds apolipoprotein A-I and mediates cellular phospholipid but not cholesterol efflux. J Biol Chem, 278: 42906-42912, 2003
52. Hayashi M, Abe-Dohmae S, Okazaki M, Ueda K, and Yokoyama S: Heterogeneity of high density lipoprotein generated by ABCA1 and ABCA7. J Lipid Res, 46: 1703-1711, 2005
53. Kim WS, Fitzgerald ML, Kang K, Okuhira K, Bell SA, Manning JJ, Koehn SL, Lu N, Moore KJ, and Freeman MW: ABCA7 null mice retain normal macrophage phosphatidylcholine and cholesterol efflux activity despite alterations in adipose mass and serum cholesterol levels. J Biol Chem, 280: 3989-3995, 2005
54. Yamamoto A, Matsuzawa Y, Yokoyama S, Funahashi T, Yamamura T, and Kishino B: Effects of probucol on xanthomata regression in familial hypercholesterolemia. Am J Cardiol, 57: 29H-35H, 1986
55. Kita T, Nagano Y, Yokode M, Ishii K, Kume N, Ooshima A, Yoshida H, and Kawai C: Probucol prevents the progression of atherosclerosis in Watanabe heritable hyperlipidemic rabbit, an animal model for familial hypercholesterolemia. Proc Natl Acad Sci USA, 84: 5928-5931, 1987
56. Sasahara M, Raines EW, Chait A, Carew TE, Steinberg D, Wahl PW, and Ross R: Inhibition of hypercholesterolemia-induced atherosclerosis in the nonhuman primate by probucol. 1. Is the extent of atherosclerosis related to resistance of LDL to oxidation? J Clin Invest, 94: 155-164, 1994
57. Yokoyama S, Yamamoto A, and Kurasawa T: A little more information about aggravation of probucol-induced HDL-reduction by clofibrate. Atheroscler, 70: 179-181, 1988
58. Johansson J, Olsson AG, Bergstrand L, Elinder LS, Nilsson S, Erikson U, Molgaard J, Holme I, and Walldius G: Lowering HDL2b by probucol partly explains the failure of the drug to affect femoral atheroscelrosis in subjects with hypercholesterolemia: A Probucol Quantitative Regression Swedish Trial (PQRST) Report. Arterioscler Thromb Vasc Biol, 15: 1049-1056, 1995
59. Tsujita M and Yokoyama S: Selective inhibition of free apolipoprotein-mediated cellular lipid efflux by probucol. Biochemistry, 35: 13011-13020, 1996
60. Tsujita M, Wu C-A, Abe-Dohmae S, Usui S, Okazaki, M, and Yokoyama S: On the hepatic mechanism of HDL assembly by the ABCA1/apoA-I pathway. J Lipid Res, 46: 154-162, 2005
61. Tsujita M, Tomimoto S, Okumura-Noji K, Okazaki M, and Yokoyama S: Apolipoprotein-mediated cellular cholesterol/phospholipid efflux and plasma high density lipoprotein level in mice. Biochim Biophys Acta, 1485: 199-213, 2000
62. Tomimoto S, Tsujita M, Okazaki M, Usui S, Tada T, Fukutomi T, Ito S, Itoh M, and Yokoyama S: Effect of probucol in lecithin-cholesterol acyltransferase deficient mice: Inhibition of two independent cellular cholesterol releasing pathways in vivo. Arterioscler Thromb Vasc Biol, 21: 394-400, 2001
63. Jonas A: Reconstitution of high-density lipoproteins. Methods Enzymol, 128: 553-582, 1986
64. Yamauchi Y, Abe-Dohmae S, and Yokoyama S: Differential regulation of apolipoprotein A-I/ATP binding cassette transporter A1-mediated cholesterol and phospholipid release. Biochim Biophys Acta, 1585: 1-10, 2002
65. Li Q and Yokoyama S: Independent regulation of cholesterol incorporation into free apolipoprotein-mediated cellular lipid efflux in rat vascular smooth muscle cells. J Biol Chem, 270: 26216-26223, 1995
66. Li Q, Tsujita M, and Yokoyama S: Selective down-regulation by protein kinase C inhibitors of apolipoprotein-mediated cellular cholesterol efflux in macrophages. Biochemistry, 36: 12045-12052, 1997
67. Bielicki JK, Johnson WJ, Weinberg RB, Glick JM, and Rothblat GH: Efflux of lipid from fibroblasts to apolipoproteins: dependence on elevated levels of cellular unesterified cholesterol. J Lipid Res, 33: 1699-1709, 1992
68. Bielicki A McCall MR, and Forte TM: Apolipoprotein A-I promotes cholesterol release and apolipoprotein E recruitment from THP-1 macrophage-like foam cells. J Lipid Res, 40: 85-92, 1999
69. Mendez AJ, Oram JF, and Bierman EL: Protein kinase C as a mediator of high density lipoprotein receptor-dependent efflux of intracellular cholesterol. J Biol Chem, 266: 10104-10111, 1991
70. Francis GA, Mendez AJ, Bierman EL, and Heinecke JW: Oxidative tyrosylation of high density lipoprotein by peroxidase enhances cholesterol removal from cultured fibroblasts and macrophage foam cells. Proc Natl Acad Sci USA, 90: 6631-6635, 1993
71. Francis GA, Oram JF, Heinecke JW, and Bierman EL: Oxidative tyrosylation of HDL enhances the depletion of cellular cholesteryl esters by a mechanism independent of passive sterol desorption. Biochemistry, 35: 15188-15197, 1996
72. Wang WQ, Merriam DL, Moses AS, and Francis GA: Enhanced cholesterol efflux by tyrosyl radical-oxidized high density lipoprotein is mediated by apolipoprotein AI-AII heterodimers. J of Biol Chem, 273: 17391-17398, 1998
73. Sviridov D and Fidge N: Efflux of intracellular versus plasma membrane cholesterol in HepG cells: different availability and regulation by apolipoprotein A-I. J Lipid Res, 36: 1887-1896, 1995
74. Rogler G, Trumbach B, Klima B, Lackner KJ, and Schmitz G: HDL-mediated efflux of intracellular cholesterol is impaired in fibroblasts from Tangier disease patients. Arterioscler Thromb Vasc Biol, 15: 683-690, 1995
75. Boyles JK, Pitas RE, Wilson E, Mahley RW, and Taylor JM: Apolipoprotein E associated with astrocytic glia of the central nervous system and with nonmyelinating glia of the peripheral nervous system. J Clin Invest, 76: 1501-1513, 1985
76. Nakai M, Kawamata TKM, and Tanaka C: Expression of apoE mRNA in rat microglia. Neurosci Lett, 211: 41-44, 1996
77. Ito J, Zhang L, Asai M, and Yokoyama S: Differential generation of high-density lipoprotein by endogenous and exogenous apolipoproteins in cultured fetal rat astrocytes J Neurochem, 72: 2362-2369, 1999
78. Fielding PE and Fielding CJ: Plasma membrane caveolae mediate the efflux of cellular free cholesterol. Biochemistry, 34: 14288-14292, 1995
79. Ito J, Nagayasu Y, and Yokoyama S: Cholesterol-sphingomyelin interaction in membrane and apolipoprotein-mediated cellular cholesterol efflux. J Lipid Res, 41: 894-904, 2000
80. Parton RG and Simons K: Digging into Caveolae. Science, 269: 1398-1399, 1995
81. Smart EJ, Ying Y-S, Conrad PA, and Anderson RGW: Caveolin moves from caveolae to the Golgi apparatus in response to cholesterol oxidation. J Cell Biology, 127: 1185-1197, 1994
82. Fielding CJ, Bist A, and Fielding PE: Caveolin mRNA levels are up-regulated by free cholesterol and down-regulated by oxysterols in fibroblasts mono-layers. Proc Natl Acad Sci USA, 94: 3753-3758, 1997
83. Bist A, Fielding PE, and Fielding CJ: Two sterol regulatory element-like sequences mediate up-regulation of caveolin gene transcription in response to low density lipoprotein free cholesterol. Proc Natl Acad Sci USA, 94: 10693-10698, 1997
84. Smart EJ, Ying Y-s. Donzell WC, and Anderson RGW: A role for caveolin in transport of cholesterol from endoplasmic reticulum to plasma membrane. J Biol Chem, 271: 29427-29435, 1996
85. Uittenbogaard A, Ying Y-s, and Smart EJ: Characterization of a cytosolic heat-shock protein-caveolin chaperone complex: involvement in cholesterol trafficking. J Biol Chem, 273: 6525-6532, 1998
86. Arakawa R, Abe-Dohmae S, Asai M, Ito J, and Yokoyama S: Involvement of caveolin-1 in cholesterol-enrichment of HDL during its assembly by apolipoprotein and THP-1 cells. J Lipid Res, 41: 1952-1962, 2000
87. Ito J, Nagayasu Y, Kato K, Sato R, and Yokoyama S: Apolipoprotein A-I induces translocation of cholesterol, phospholipid and caveolin-1 to cytosol in rat astrocytes. J Biol Chem, 7929-7935, 2002
88. Ito J, Li H, Nagayasu Y, Kheirollah A, and Yokoyama S: Apolipoprotein A-I induces translocation of protein kinase Ca to a cytosolic lipid-protein particle in astrocytes. J Lipid Res, 45: 2269-2276, 2004
89. Fielding CJ and Fielding PE: Evidence for a lipoprotein carrier in human plasma catalyzing sterol efflux from cultured fibroblasts and its relationship to lecithin: cholesterol acyltransferase. Proc Natl Acad Sci USA, 78: 3911-3914, 1981
90. Kilsdonk EPC, Dorsman ANRD, and van Tol A: Effect of LCAT on HDL-mediated cholesterol efflux from loaded EA.hy 926 cells. Int J Bioohem, 25: 219-221, 1993
91. Oram JF, Mendez AJ, Slotte JP, and Johnson TF: High density lipoprotein apolipoproteins mediate removal of sterol from intracellular pools but not from plasma membranes of cholesterol-loaded fibroblasts. Artrioscler Thromb, 11: 403-414, 1991
92. Glomset JA: The lecithin: cholesterol acyltransferase reaction. J Lipid Res, 9: 155-167, 1968
93. Hara H and Yokoyama S: Role of apolipoproteins in cholesterol efflux from macrophages to lipid microemulsion: Proposal of a putative model for the pre-b high-density lipoprotein pathway. Biochemistry, 31: 2040-2046, 1992
94. Tajima S, Yokoyama S, and Yamamoto A: Effect of lipid particle size on association of apolipoproteins with lipid. J Biol Chem, 258: 10073-10082, 1983
95. Okabe H, Yokoyama S, and Yamamoto A: Modulation of cholesterol microenvironment with apolipoproteins induced by the presence of cholesteryl ester in lipid microemulsion. J Biochem, 104: 141-148, 1988
96. Liang H-Q, Rye K-A, and Barter PJ: Dissociation of lipid-free apolipoprotein A-I from high density lipoproteins. J Lipid Res, 35: 1187-1199, 1994
97. Liang H-Q, Rye K-A, and Barter PJ: Cycling of apolipoprotein A-I between lipid-associated and lipid-free pools. Biochim Biophys Acta, 1257: 31-37, 1995
98. Clay MA, Newnham HH, Forte TM, and Barter PI: Cholesteryl ester transfer protein and hepatic lipase activity promote shedding of apo A-I from HDL and subsequent formation of discoidal HDL. Biochim Biophys Acta, 1124: 52-58, 1992
99. Pussinen P, Juahiainen M, Metso J, Tyynela J, and Ehnholm C: Pig plasma phospholipid transfer protein facilitates HDL interconversion. J Lipid Res, 36: 975-985, 1995
100. Wolfbauer G, Albers JJ, and Oram JF: Phospholipid transfer protein enhances removal of cellular cholesterol and phospholipids by high-density lipoprotein apolipoproteins. Biochim Biophys Acta, 1439: 65-76, 1999
101. Komaba A, Li Q, Hara H, and Yokoyama S: Resistance of smooth muscle cells to assembly of high density lipoproteins with extracellular free apolipoproteins and to reduction of intracellularly accumulated cholesterol. J Biol Chem, 267: 17560-17566, 1992
102. Okuhira K, Tsujita M, Yamauchi Y, Abe-Dohmae S, Kato K, Handa T, and Yokoyama S: Potential involvement of dissociated apoA-I in the ABCA1-dependent cellular lipid release by HDL. J Lipid Res, 45: 645-652, 2004
103. Castro GR and Fielding CJ: Early incorporation of cell-derived cholesterol into pre-b-migrating high-density lipoprotein. Biochemistry, 27: 25-29, 1988
104. Miida T, Kawano M, Fielding CJ, and Fielding PE: Regulation of the concentration of preb high density lipoprotein in normal plasma by cell membranes and lecithin-cholesterol acyltransferase activity. Biochemistry, 31: 11112-11117, 1992
105. Kuwano M, Miida T, Fielding CJ, and Fielding PE: Quantitation of preb-HOL and nonspecific components of the total efflux of cellular cholesterol and phospholipid. Biochemistry, 32: 5025-5028, 1993
106. Bell-Quint J and Forte T: Time-related changes in the synthesis and secretion of very low density, low density and high density lipoproteins by cultured rat hepatocytes. Biochim Biophys Acta, 663: 83-98, 1981
107. Cheung MC, Lum KD, Brouillette CG, and Bisgaier CL: Characterization of apoA-I-containing lipoprotein subpopulations secreted by HepG2 cells. J Lipid Res, 30: 1429-1436, 1989
108. Sorci-Thomas M, Prack MM, Dashti N, Johnson F, Rudel LL, and Williams DL: Apolipoprotein (apo) A-I production and mRNA abundance explain plasma apoA-I and high density lipoprotein differences between two nonhuman primate species with high and low susceptibilities to diet-induced hypercholesterolemia. J Biol Chem, 263: 5183-5189, 1988
109. Sorci-Thomas M, Prack MM, Dashti N, Johnson F, Rudel LL, and Williams DL: Differential effects of dietary fat on the tissue-specific expression of the apolipoprotein A-I gene: relationship to plasma concentration of high density lipoproteins. J Lipid Res, 30: 1397-1403, 1989
110. Zhang W-Y, Gaynor PM, and Kruth HS: Apolipoprotein E produced by human monocyte-derived macrophages mediates cholesterol efflux that occurs in the absence of added cholesterol acceptors. J Biol Chem, 271: 28641-28646, 1996
111. Chisholm JW, Burleson ER, Shelness GS, and Parks JS: ApoA-I secretion from HepG2 cells: evidence for the secretion of both lipid-poor apoA-I and intracellularly assembled nascent HDL. J Lipid Res, 43: 36-44, 2002
112. Kiss RS, McManus DC, Franklin V, Tan WL, McKenzie A, Chimini G, and Marcel YL: The lipidation by hepatocytes of human apolipoprotein A-I occurs by both ABCA1-dependent and -independent pathways. J Biol Chem, 278: 10119-10127, 2003
113. Costet P, Luo Y, Wang N, and Tall AR: Sterol-dependent transactivation of the ABC1 promoter by the liver X receptor/retinoid X receptor. J Biol Chem, 275: 28240-28245, 2000
114. Schwartz K, Lawn RM, and Wade DP: ABC1 gene expression and ApoA-I-mediated cholesterol efflux are regulated by LXR. Biochem Biophys Res Commun, 274: 794-802, 2000
115. Venkateswaran A, Laffitte BA, Joseph SB, Mak PA, Wilpitz DC, Edwards PA, and Tontonoz P: Control of cellular cholesterol efflux by the nuclear oxysterol receptor LXR alpha. Proc Natl Acad Sci USA, 97: 12097-12102, 2000
116. Costet P, Lalanne F, Gerbod-Giannone MC, Molina JR, Fu X, Lund EG, Gudas LJ, and Tall AR: Retinoic acid receptor-mediated induction of ABCA1 in macrophages. Mol Cell Biol, 23: 7756-7766, 2003
117. Langmann T, Klucken J, Reil M, Liebisch G, Luciani M-F, Chimini G, Kaminski WE, and Schmitz G: Molecular cloning of the human ATP-binding cassette transporter 1 (hABC1): evidence for sterol-dependent regulation in macrophage. Biochem Biophys Res Commun, 257: 29-33, 1999
118. Sugimoto K, Tsujita M, Wu CA, Suzuki K, and Yokoyama S: An inhibitor of acylCoA: cholesterol acyltransferase increases expression of ATP-binding cassette transporter A1 and thereby enhances the ApoA-I-mediated release of cholesterol from macrophages. Biochim Biophys Acta, 1636: 69-76, 2004
119. Yamauchi Y, Chang CC, Hayashi M, Abe-Dohmae S, Reid PC, Chang TY, and S Y: Intracellular cholesterol mobilization involved in the ABCA1/ apolipoprotein-mediated assembly of high density lipoprotein in fibroblasts. J Lipid Res, 45: 1943-1951, 2004
120. Sparrow CP, Baffic J, Lam MH, Lund EG, Adams AD, Fu X, Hayes N, Jones AB, Macnaul KL, Ondeyka J, Singh S, Wang J, Zhou G, Moller DE, Wright SD, and Menke JG: A potent synthetic LXR agonist is more effective than cholesterol loading at inducing ABCA1 mRNA and stimulating cholesterol efflux. J Biol Chem, 277: 10021-10027, 2002
121. Chinetti G, Lestavel S, Bocher V, Remaley AT, Neve B, Torra IP, Teissier E, Minnich A, Jaye M, Duverger N, Brewer BH, Fruchart JC, Clavey V, and Staels B; PPAR-alpha and PPAR-gamma activators induce cholesterol removal from human macrophage foam cells through stimulation of the ABCA1 pathway. Nat, Med. 1, 2001
122. Murthy S, Born E, Mathur SN, and Field FJ: LXR/RXR activation enhances basolaterall efflux of cholesterol in CaCo-2 cells. J Lipid Res, 43: 1054-1064, 2002
123. Lin G and Bornfeldt KE: Cyclic AMP-specific phosphodiesterase 4 inhibitors promote ABCA1 expression and cholesterol efflux. Biochem Biophys Res Commun, 290: 663-669, 2002
124. Suzuki S, Nishimaki-Mogami T, Tamehiro N, Inoue K, Arakawa R, Abe-Dohmae S, Tanaka AR, Ueda K, and Yokoyama S: Verapamil increases the apolipoprotein-mediated release of cellular cholesterol by induction of ABCA1 expression via Liver X receptor-independent mechanism. Arterioscler Thromb Vasc Biol, 24: 519-525, 2004
125. Miao B, Zondlo S, Gibbs S, Cromley D, Hosagrahara VP, Kirchgessner TG, Billheimer J, and Mukherjee R: Raising HDL cholesterol without inducing hepatic steatosis and hypertriglyceridemia by a selective LXR modulator. J Lipid Res, 45: 1410-1417, 2004
126. Arakawa R and Yokoyama S: Helical apolipoproteins stabilize ATP-binding cassette transporter A1 by protecting it from thiol protease-mediated degradation. J Biol Chem, 277: 22426-22429, 2002
127. Wang N, Chen W, Linsel-Nitschke P, Martinez LO, Agerholm-Larsen B, Silver DL, and Tall AR: A PEST sequence in ABCA1 regulates degradation by calpain protease and stabilization of ABCA1 by apoA-I. J Clin Invest, 111: 99-107, 2003
128. Yamauchi Y, Hayashi M, Abe-Dohmae S, and Yokoyama S: Apolipoprotein A-I activates protein kinase Ca signaling to phosphorylate and stabilize ATP binding cassette transporter A1 for the high density lipoprotein assembly. J Biol Chem, 278: 47890-47897, 2003
129. Arakawa R, Hayashi M, Remaley AT, Brewer BH Jr, Yamauchi Y, and Yokoyama S: Phosphorylation and stabilization of ATP binding cassette transporter A1 by synthetic amphiphilic helical peptides. J Biol Chem, 279: 6217-6220, 2004
130. Ito J, Nagayasu Y, Ueno S, and Yokoyama S: Apolipoprotein-mediated cellular lipid release requires replenishment of sphingomyelin in a phosphatidylcholine-specific phospholipase C-dependent manner. J Biol Chem, 277: 44709-44714, 2002
131. Martinez LO, Agerholm-Larsen B, Wang N, Chen W, and Tall AR: Phosphorylation of a pest sequence in ABCA1 promotes calpain degradation and is reversed by ApoA-I. J Biol Chem 278: 37368-37374, 2003
132. Chen W, Wang N, and Tall AR: A PEST Deletion Mutant of ABCA1 Shows Impaired Internalization and Defective Cholesterol Efflux from Late Endosomes. J Biol Chem, 280: 29277-29281, 2005
133. Wu C-A, Tsujita M, Hayashi M, and Yokoyama S: Probucol Inactivates ABCA1 in Plasma Membrane for its Function to Mediate Apolipoprotein Binding and HDL Assembly and for its Proteolytic Degradation. J Biol Chem, 279: 30168-30174, 2004
134. Favari E, Zanotti I, Zimetti F, Ronda N, Bernini F, and Rothblat GH: Probucol inhibits ABCA1-mediated cellular lipid efflux. Arterioscler Thromb Vasc Biol, 24: 2345-2350, 2004
135. Le Goff W, Peng DQ, Settle M, Brubaker G, Morton RE, and Smith JD: Cyclosporin A traps ABCA1 at the plasma membrane and inhibits ABCA1 -mediated lipid efflux to apolipoprotein A-I. Arterioscler Thromb Vasc Biol, 24: 2155-2161, 2004
136. Glomset JA, Assmann G, Gjone E, and Norum KR: Lecithin: cholesterol acyltransferase deficiency and fish eye disease. In The Metabolic and Molecular Bases of Inherited Disease, 7th Edition. C.R. Sciver, A.L. Beaudet, W.S. Sly, and d. Valle, editors. New York: McGraw-Hill, Inc. Health Profession Division. 1933-1952, 1995